Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billion as experimental treatments gain traction
CNBC · C · trust 46/100
The deal for AtaiBeckley gives Lilly access to experimental drugs based on DMT and MDMA.
Read the original at CNBC →
Open in TruthVane →